Ajay Kayal

Ajay Kayal focuses on opinion drafting, patent litigation, and strategic client counseling in patent cases arising under the Hatch-Waxman Act. He has extensive experience in the preparation of invalidity, non-infringement, and freedom to operate opinions and notice letters in connection with Abbreviated New Drug Application (ANDA) filings by generic pharmaceutical clients.

He routinely counsels generic pharmaceutical clients on a variety of issues, including product selection, strategy for ANDA and 505b2 NDA filings, risk assessments, and designing around process, polymorph, and formulation patents. He also collaborates with litigation teams to develop strategy and works with experts in litigation. Ajay worked as a Technical Advisor prior to and during law school. He holds a Ph.D. in Chemistry from Princeton University (2002) and a J.D. from Rutgers University School of Law - Newark (2009).